Dermavant Reports Positive Topline Results from ADORING 2 Atopic Dermatitis Phase 3 Trial of VTAMA® (tapinarof) Cream, 1% Once Daily in Adults and Children as Young as 2 Years Old

LONG BEACH, Calif. & BASEL, Switzerland–(BUSINESS WIRE)– #AtopicDermatitis–Dermavant Reports Positive Topline Results from ADORING 2 Atopic Dermatitis Phase 3 Trial of VTAMA® Cream, 1% Once Daily in Adults and Children